Filing Details

Accession Number:
0001654954-17-005235
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-05-31 17:28:57
Reporting Period:
2017-05-30
Filing Date:
2017-05-31
Accepted Time:
2017-05-31 17:28:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
810509 Navidea Biopharmaceuticals Inc. NAVB In Vitro & In Vivo Diagnostic Substances (2835) 311080091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1554593 Jed Latkin 4995 Bradenton Ave
Suite 240
Dublin OH 43017
Coo And Cfo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.001 Par Value Acquisiton 2017-05-30 7,600 $0.44 50,159 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct